The relationship between sarcopenia and non-alcoholic fatty liver disease (NAFLD) is intriguing and extremely topical, when we consider the increasing prevalence of the manifestations of NAFLD and non-alcoholic steatohepatitis (NASH) worldwide, together with the overwhelming burden of aging-related disease conditions such as sarcopenia. Such an association was described mainly in Eastern Asian populations and different indices of fat infiltration, including computed tomography (CT) were utilized. On the other hand, the evidence in the industrialized countries of the Western world is rather limited. The present findings replicate the association between liver and muscle fat infiltration in an older Western population, and using a densitometr...
Recent studies have investigated the relationship between sarcopenia and non-alcoholic fatty liver d...
: Sarcopenia is increasingly recognized in patients with nonalcoholic liver disease (NAFLD). Initial...
: Sarcopenia is increasingly recognised in patients with non-alcoholic liver disease (NAFLD). Initia...
The relationship between sarcopenia and non-alcoholic fatty liver disease (NAFLD) is intriguing and ...
A relationship between nonalcoholic fatty liver disease (NAFLD) and sarcopenia has been suggested. T...
International audienceAn extensive body of the literature shows a strong interrelationship between t...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
Aim. Previous studies have shown that individuals with low muscle mass exhibit an increased risk of ...
The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it i...
Sarcopenia is associated with nonalcoholic fatty liver disease (NAFLD). This study investigated whet...
Sarcopenia is defined as a loss of muscle strength, mass and function and it is a predictor of morta...
Non-alcoholic fatty liver disease (NAFLD) has reached epidemic proportions, affecting an estimated o...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
Background: Sarcopenia recognises insulin resistance and obesity as risk factors, and is frequently ...
Accumulating evidence supports a connection between sarcopenic obesity (SO) and NAFLD. The extent to...
Recent studies have investigated the relationship between sarcopenia and non-alcoholic fatty liver d...
: Sarcopenia is increasingly recognized in patients with nonalcoholic liver disease (NAFLD). Initial...
: Sarcopenia is increasingly recognised in patients with non-alcoholic liver disease (NAFLD). Initia...
The relationship between sarcopenia and non-alcoholic fatty liver disease (NAFLD) is intriguing and ...
A relationship between nonalcoholic fatty liver disease (NAFLD) and sarcopenia has been suggested. T...
International audienceAn extensive body of the literature shows a strong interrelationship between t...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
Aim. Previous studies have shown that individuals with low muscle mass exhibit an increased risk of ...
The link between metabolic syndrome (MetS) and sarcopenia has not been extensively studied, but it i...
Sarcopenia is associated with nonalcoholic fatty liver disease (NAFLD). This study investigated whet...
Sarcopenia is defined as a loss of muscle strength, mass and function and it is a predictor of morta...
Non-alcoholic fatty liver disease (NAFLD) has reached epidemic proportions, affecting an estimated o...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
Background: Sarcopenia recognises insulin resistance and obesity as risk factors, and is frequently ...
Accumulating evidence supports a connection between sarcopenic obesity (SO) and NAFLD. The extent to...
Recent studies have investigated the relationship between sarcopenia and non-alcoholic fatty liver d...
: Sarcopenia is increasingly recognized in patients with nonalcoholic liver disease (NAFLD). Initial...
: Sarcopenia is increasingly recognised in patients with non-alcoholic liver disease (NAFLD). Initia...